Eli Lilly and Company
TrkA Inhibitor

Abstract:

The present invention relates to compound of the following structure ##STR00001## for use as an inhibitor of TrkA, as well as compositions including this compound, and methods of using this compound for the treatment of pain including post-surgical pain, rheumatoid arthritis pain, neuropathic pain and osteoarthritis pain.